Biotech Values

[dewophile]

I'm not sure how pharmas make decisions on how to allocate reps..I would hope it is based on well thought out algorithms, including where the best margins are, amount of competition in that space, geographical and individual prescribing trends, etc..if that calculation spits out that the best reps should in fact see gps because they jsut can't keep up with all the txs out there, or specialists because they are writing a 3 thousand dollar prescription for a specialty med with 2-3 competing alternatives (that is specifically the case in my field) so be it. seems to me like it should be more product specific than anything else. I do know there are performance incentives, and reps are often ranked based on relative market share for the docs on whom they call, so there is some tracking mechanism of sorts, although I don't doubt there are still plenty of inefficiencies in the system